Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PROFILE: Tomas Salmonson, chair of the EMA's CHMP, on European collaboration, being a teenage lifeguard, and Persian rugs

This article was originally published in Scrip

Executive Summary

The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) is the body that effectively says yes or no to your new drug in Europe. Since September 2012, the committee has been chaired by senior Swedish regulator Tomas Salmonson. In this profile, by Francesca Bruce, find out what Dr Salmonson thinks of the pharmaceutical industry and what key advice he would give companies looking for regulatory approval… and also how he relaxes, what shaped him growing up and why he thinks his grandfather would be proud of him.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts